Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIOV News
Recent news which mentions BIOV News
BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine
December 01, 2022
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps
October 06, 2022
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine Trial and Enters into Second Tumor Cell Supply Agreement
May 18, 2022
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys Enters Critical Tumor Cell Supply Agreement with Deaconess Research Institute for BVX-0918 Bioproduction
April 25, 2022
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS ANNOUNCES MAJOR RESEARCH COLLABORATION WITH THE OHIO STATE UNIVERSITY TO DEVELOP BROADLY REACTIVE PAN-SARBECOVIRUS VACCINE
December 07, 2021
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys announces that CoviDTH Demonstrates Safety and Tolerability in Broad Ranging In Vivo Clinical Pathology, Immunology, and Histopathology Evaluation, Supporting Planned Clinical Development of
November 09, 2021
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine
October 20, 2021
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS BEGINS TOXICITY STUDY AHEAD OF COVIDTH IND SUBMISSION
September 28, 2021
Tickers
BIOV
BVAXF
NOTV
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS PREPARES FOR GROUND-BREAKING STUDY ON REDUCED ACE2 BINDING CAPABILITIES OF HAPTEN-MODIFIED SARS-COV-2 PROTEINS
September 23, 2021
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS CANCER VACCINE MANUFACTURING PARTNER BIO ELPIDA REACHES BIOPRODUCTION MILESTONE
September 17, 2021
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS BIOPRODUCTION PARTNER WUXI BIOLOGICS COMPLETES SYNTHESIS OF RECOMBINANT SARS-COV-2 S-PROTEINS FOR BVX-0320 AND CoviDTH PROGRAMS
September 14, 2021
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
FURTHER STUDY IN HUMANS SHOWS THAT THE DTH RESPONSE, THE BASIS FOR CoviDTH, IS HIGHLY DURABLE AND PERSISTS FOR AT LEAST ONE YEAR AFTER COVID-19 EXPOSURE OR VACCINE ADMINISTRATION
September 08, 2021
Tickers
BIOV
BVAXF
Tags
Featured News
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
FDA PROVIDES NECESSARY GUIDANCE FOR BIOVAXYS TO BEGIN PREPARATION OF IND FOR PHASE I/II CLINICAL TRIALS OF CoviDTH
July 22, 2021
Tickers
BIOV
BVAXF
Tags
BIOV News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.